Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi USD Corporate Bond ESG UCITS ETF Hedged EUR Dist
UCRH · LU2297533809 · class UCITS ETF Hedged EUR Dist · EUR · domicile Luxembourg
Bonds · Corporate USD · Broad (all maturities) · North AmericaEUR-hedged share classSFDR art. 8
Index tracked: Bloomberg MSCI ESG US Corporate Select Index
- TER
- 0.18%+ trans. 0.03%
- Fund size
- 333 m EUR
- Tracking difference
- −0.18%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
- Duration
- 5.89 yrsmedium (3–7 years)
Launch 3 Mar 2021 · costs from the KID as of 2 Sept 2026 · 4,345 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg MSCI ESG US Corporate Select Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Total Return Index : the coupons paid by the index constituents are included in the index return. The Sub-Fund promotes environmental and/or social…
Performance since series start (in euro) — base 100
3 Mar 2021 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | −1.5% |
| 3 years | +9.2% |
| 5 years | −10.6% |
| 10 years | series too young |
| Since series start | −8.5% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.48% | 6.48% | 7.20% |
| Max drawdown | −6.64% | −8.90% | −26.94% |
| Sharpe | -1.44 | -0.61 | -1.11 |
| Sortino | -1.59 | -0.73 | -1.37 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · UCRH · LU22975338091
RebalixUCRH · LU2297533809 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +5.33% | +5.42% | −0.09% |
| 2024 | +0.10% | +0.30% | −0.19% |
| 2023 | +5.44% | +5.71% | −0.27% |
| 2022 | −17.35% | −17.32% | −0.03% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in EUR
Frequency: annual · last 12 months: 1.61 EUR (4.21% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 1.61 | +4.17% |
| 2024 | 1 | 1.58 | +3.94% |
| 2023 | 1 | 1.57 | +3.97% |
| 2022 | 1 | 1.61 | +3.23% |
| 2021 | 1 | 0.86 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 4,345 securities · top-10 weight = 1.3%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
UCRH · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2297533809
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2297533809
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · UCRH · LU22975338092